These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
397 related items for PubMed ID: 18617021
21. Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin's lymphoma. Bencimon C, Salles G, Moreira A, Guyomard S, Coiffier B, Bienvenu J, Fabien N. Ann N Y Acad Sci; 2005 Jun; 1050():319-26. PubMed ID: 16014548 [Abstract] [Full Text] [Related]
23. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis. Villalta D, Morozzi G, Tampoia M, Alpini C, Brusca I, Salgarolo V, Papisch W, Bizzaro N. Clin Chim Acta; 2010 May 02; 411(9-10):710-3. PubMed ID: 20138166 [Abstract] [Full Text] [Related]
24. Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnostic performance and correlation with conventional techniques. Bonroy C, Smith V, Van Steendam K, Van Praet J, Deforce D, Devreese K, De Keyser F. Clin Exp Rheumatol; 2012 May 02; 30(5):748-55. PubMed ID: 22765957 [Abstract] [Full Text] [Related]
25. Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th/To autoantigen. Mahler M, Fritzler MJ, Satoh M. Autoimmun Rev; 2015 Mar 02; 14(3):254-7. PubMed ID: 25462581 [Abstract] [Full Text] [Related]
31. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody. Komura K, Yanaba K, Ogawa F, Shimizu K, Takehara K, Sato S. Clin Exp Dermatol; 2008 May 02; 33(3):329-32. PubMed ID: 18312458 [Abstract] [Full Text] [Related]
32. Autoantibodies in systemic sclerosis (scleroderma): clues for clinical evaluation, prognosis and pathogenesis. Grassegger A, Pohla-Gubo G, Frauscher M, Hintner H. Wien Med Wochenschr; 2008 May 02; 158(1-2):19-28. PubMed ID: 18286246 [Abstract] [Full Text] [Related]
37. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis. Kim D, Peck A, Santer D, Patole P, Schwartz SM, Molitor JA, Arnett FC, Elkon KB. Arthritis Rheum; 2008 Jul 02; 58(7):2163-73. PubMed ID: 18576347 [Abstract] [Full Text] [Related]
38. A cross-sectional study of autoantibody profiles in the Waikato systemic sclerosis cohort, New Zealand. Chang WS, Schollum J, White DH, Solanki KK. Clin Rheumatol; 2015 Nov 02; 34(11):1921-7. PubMed ID: 26022620 [Abstract] [Full Text] [Related]
40. Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma. Chen M, Dittmann A, Kuhn A, Ruzicka T, von Mikecz A. Arthritis Rheum; 2005 Mar 02; 52(3):877-84. PubMed ID: 15751092 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]